CoChat

Drug‐induced hepatic injury in children: a case/non‐case study of suspected adverse drug reactions in VigiBase

Open access
Ferrajolo, Carmen, Capuano, Annalisa, Verhamme, Katia M. C., Schuemie, Martijn, Rossi, Francesco, Stricker, Bruno H., Sturkenboom, Miriam C. J. M. · 2010 · British Journal of Clinical Pharmacology
Cited by 68

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Drug‐induced hepatic injury is one of the most important reasons for drug withdrawal in adults. • Very little is known about drug‐induced hepatic injury in children and adolescents. WHAT THIS STUDY ADDS • The rate of hepatic injury as suspected adverse drug reactions in the paediatric population is low. • Drugs associated with hepatotoxicity in children and adolescents were mostly known to be associated with hepatotoxicity in adults as well. AIM: To identify which drugs are associated with reports of suspected hepatic injury in children and adolescents. METHODS: Using a worldwide pharmacovigilance database, VigiBase, we conducted a case/non‐case study on suspected adverse drug reactions (ADRs) occurring in the population <18 years old. Cases were all the records with hepatic ADRs and non‐cases were all the other ADR records. Records regarding topically administered drugs were excluded from both groups. The association between drug and suspected hepatic ADRs was calculated using the reporting odds ratio (ROR) as a measure of disproportionality while adjusting for gender, country, reporter and calendar year. Sub‐analyses were performed within therapeutic class and by excluding vaccination‐related reports to reduce confounding. RESULTS: Overall, 6595 (1%) out of 624 673 ADR records in children and adolescents concerned hepatic injury. Most of the reported hepatic injuries concerned children 12–17 years of age. Drugs that were most frequently reported as suspected cause and were associated with hepatic injury comprised paracetamol, valproic acid, carbamazepine, methotrexate, minocycline, zidovudine, pemoline, ceftriaxone, bosentan, ciclosporin, atomoxetine, olanzapine, basiliximab, erythromycin and voriconazole. The association between hepatotoxicity and all these drugs, except for basiliximab, is already known. CONCLUSIONS: Drug‐induced hepatic injury is infrequently reported (only 1% of total) as a suspected ADR in children and adolescents. The drugs associated with reported hepatotoxicity (paracetamol, antiepileptic and anti‐tuberculosis agents) are known to be hepatotoxic in adults as well, but age related changes in associations were observed. VigiBase is useful as a start to plan further drug safety studies in children.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.2010.03754.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 68

Metadata

Authors
Ferrajolo, C., Capuano, A., Verhamme, K. M. C., Schuemie, M., Rossi, F., Stricker, B. H., & Sturkenboom, M. C. J. M.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2010-07-15
Volume
70
Issue
5
Pages
721-728
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W2126029463
Cited by
68
References
1
FWCI
4.46
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug‐induced hepatic injury in children: a case/non‐case study of suspected adverse drug reactions in VigiBase. https://app.cochat.ai/papers/10.1111/j.1365-2125.2010.03754.x
The paper
Ferrajolo, C., Capuano, A., Verhamme, K. M. C., Schuemie, M., Rossi, F., Stricker, B. H., & Sturkenboom, M. C. J. M. (2010). Drug‐induced hepatic injury in children: a case/non‐case study of suspected adverse drug reactions in VigiBase. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2010.03754.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.